Mylan CEO Heather Bresch says the EpiPen price increase was necessary but the company will offer a $300 generic option Julie Mazziotta is the Senior Sports Editor at PEOPLE, covering everything ...

CVS (operating in Hawaii as Longs Drugs) is now selling a rival, generic version of Mylan’s EpiPen at about a sixth of its price, just months after the maker of the life-saving allergy treatment ...

Mylan's settlement with drug wholesalers comes on the heels of the company reaching a $264 million settlement for consumers ...

A backlash against the hugely increased price of its EpiPen product has led Mylan to announce the launch of a generic version. The company has become engulfed in controversy around its US EpiPen ...

several companies created EpiPen substitutions and the Food and Drug Administration approved the first generic alternative, but EpiPen had name-brand recognition. Speaking with PEOPLE at the time ...

People or entities who purchased EpiPen® or generic EpiPen directly from Mylan or Teva, for resale, at any time during the period from March 13, 2014, until the date on which the Court entered ...

Maniar says because of these concerns, many people with allergies don't carry an EpiPen or generic injectable. According to ARS Pharma, the manufacturer of the nasal spray, only 3.2 million of the ...

Epinephrine has been used since 1901 and is ... As a result of the outcry, Mylan began selling an “authorized generic” for ...

There's a very good reason why the EpiPen's 500% price increase drew so much attention, even though there are other emergency auto-injecting devices available that can be used to treat severe ...

The complaint centers on generic, rather than brand-name ... competitive coordination between companies, as opposed to the EpiPen outrage which involved only Mylan. In that case, the company ...